United States
Tiger
Download
TigerGPT
Help
LOGIN
SIGN UP
Toggle
C
CorMedix Inc.'s 2024Q4 financial report review
US
CRMD
Mar25th Tuesday
Pre-market
Earnings Overview
Financial Data
Actual
YoY
Estimates
EPS
0.22
184.62%
0.14
Revenue
31.21M
-
26.53M
EBIT
12.94M
182.56%
10.66M
News
Market Insights
What's the highlight of CorMedix Inc.'s financial report?
Talk to TigerAI
Start
Exclusive Benefits
Analyst Forecast
C
CorMedix Inc.
US
CRMD
Mar25th Tuesday
Pre-market
Analyst Price Targets
Data Last updated:
Analyst Recommendations
Relevant Information
Feedback
Welcome to share with us your comments or feedback
*T&Cs Apply. Capital at Risk, Not Investment Advice.
Learn more
{"basename":"/earnseason","ssrTDKData":{"titleTemplate":"%s","title":"Tiger Trade _ US, HK & SG stocks, ETFs & US options","description":"A top trading platform from a NASDAQ listed company enables investors to invest in the global giants from only USD 1, and here you can access to investment products including US stocks, SG stocks, HK stocks, ETFs, US options, US fractional shares & auto invest on multiple global markets including Nasdaq, New York Stock Exchange, Hong Kong Stock Exchange & Singapore Stock Exchange","keywords":"Tiger Trade,US stock trading,Hong Kong stock trading,Singapore trading,US stocks,top US stocks,stock information,stock prices,US stock quotes,buying US stocks,global investment,trading,trading platform,US options,ETFs","social":{"ogDescription":"A top trading platform from a NASDAQ listed company enables investors to invest in the global giants from only USD 1, and here you can access to investment products including US stocks, SG stocks, HK stocks, ETFs, US options, US fractional shares & auto invest on multiple global markets including Nasdaq, New York Stock Exchange, Hong Kong Stock Exchange & Singapore Stock Exchange","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.be62fbe1.png","ogUrl":"https://www.tigertrade.app/earnseason/CRMD"},"companyName":"Tiger"},"pageData":{"pageTitle":"Tiger Trading Season","headTitle":"CorMedix Inc.'s 2024Q4 financial report review","feedBackDisplay":true,"financialNewsMaxNum":3,"keyData":[{"nameChs":"调整后每股收益","nameCht":"調整後每股收益","nameEng":"EPS","actualValue":0.22,"expectedValue":0.14,"yoyGrowth":1.84615,"name":"EPS"},{"nameChs":"收入","nameCht":"收入","nameEng":"Revenue","actualValue":31209000,"expectedValue":26531400,"name":"Revenue"},{"nameChs":"息税前利润","nameCht":"息稅前利潤","nameEng":"EBIT","actualValue":12936000,"expectedValue":10655500,"yoyGrowth":1.82559,"name":"EBIT"}],"tigerGpt":{"internalJumpUrl":null,"externalJumpUrl":null},"beforeOrAfter":"after","shareConfig":{"socialMediaImage":"https://static.tigerbbs.com/461bf91ab2e2283e68395ea16fd95e8e","weChatImage":"https://static.tigerbbs.com/55353f4879f69c699f0109fe402ca704","title":"CRMD's Earnings Review","description":"View key performance metrics of CRMD's earnings in one chart and explore more opportunities."},"analystRecommendations":[{"market":"US","symbol":"CRMD","logo":null,"reportTime":"Pre-Market","isReport":true,"date":"20250325","nameEng":"CorMedix Inc.","timestamp":1742832000000,"name":"CorMedix Inc."}],"stockInfo":{"market":"US","symbol":"CRMD","logo":null,"reportTime":"Pre-Market","isReport":true,"date":"20250325","timestamp":1742832000000,"name":"CorMedix Inc.","nameEng":"CorMedix Inc."}},"pageError":null,"isTTM":true,"isTiger":false,"isTigerTradeLite":false,"license":"TBMS","region":"IDN","edition":"full_ms","isOpenedInApp":true}